Lupin, Zydus to co-market semaglutide injection in India

Lupin and Zydus will co-market semaglutide injection in India. Lupin will use Semanext and Livarise, while Zydus will use Semaglyn, Mashema, and Alterme.

Lupin and Zydus will co-market semaglutide injection in India. Lupin will use Semanext and Livarise, while Zydus will use Semaglyn, Mashema, and Alterme.

Eternal shares have corrected nearly 40% from its recent highs. Brokerage firm JM Financial said the stock now appears attractively valued at around 35x its estimated FY28 earnings.

Maruti Suzuki said it has received a ₹5,786 crore draft tax assessment order for FY23 from the Income Tax Department and will challenge it.

Mastek (UK) Ltd won a £15 million two-year contract from the UK’s Financial Conduct Authority, to help scale and modernise the regulator’s digital platforms and processes.

Investors are turning to dividend-paying stocks amid market swings. Colgate-Palmolive, Johnson & Johnson, and Fastenal are outperforming with dividend yields of 2.39%, 2.15%, and 2.11% respectively.

Cash levels for India’s mutual funds as a percentage of the overall Assets Under Management remained nearly the same in February, compared to the month of January, as per a recent analysis from brokerage firm JM Financial.

Andhra Petrochemicals Ltd suspended operations at its Visakhapatnam plant on March 17 after Hindustan Petroleum halted propylene supply due to geopolitical conflicts.
Jonathan Garner, Chief Asia and Emerging Markets Equity Strategist, Morgan Stanley, says the risk is not just higher oil prices but disruption in supply flows across oil and gas. He flags that this could hit industrial production, including fertilisers, and…

Brokerage firm Macquarie said that margin pressures are likely to remain a near-term concern for paint manufacturers due to elevated input costs.

The Indian rupee opened stronger at 92.39 against the US dollar on March 17, up from 92.42 on March 16, aided by a pause in crude oil price rally and better global risk sentiment.